If a diabetic patient with hypertension is well-managed on metformin and experiences hypertension, what is the preferred hypertension treatment?

Study for the Board Certified Cardiology Pharmacist Exam. Utilize flashcards and answer multiple-choice questions with detailed explanations. Prepare efficiently for your certification!

The preferred treatment option for a diabetic patient with hypertension who is well-managed on metformin is to use an angiotensin receptor blocker (ARB). This is because ARBs offer several benefits for patients with diabetes and hypertension. They help to manage blood pressure effectively while also providing renal protection, which is particularly important for diabetic patients due to their increased risk of kidney complications. ARBs work by blocking the action of angiotensin II, leading to vasodilation, reduced blood pressure, and decreased strain on the cardiovascular system.

In addition to their antihypertensive effects, ARBs also have favorable effects on glucose metabolism and can help reduce microalbuminuria, which is a common concern in diabetic patients. These attributes make ARBs a cornerstone in the management of hypertension in individuals with diabetes.

Choosing other options, such as starting a beta-blocker, increasing the dose of gliclazide, or initiating only non-pharmacological interventions, would not align as well with current treatment guidelines for managing hypertension in diabetic patients. Beta-blockers may not provide the same renal protective effects as ARBs, and while gliclazide is a medication used for glycemic control, increasing its dose does not directly address hypertension. Non-pharmacological interventions are important

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy